Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-11-18
DOI: 10.1111/apt.71109 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-11-18. Written by Juma A Mohamedi and 2 co-authors. Institution: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. 7 references. Funded by: VLIRUOS.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
- Department of Pharmaceutics, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
- Department of Gastroenterology, HUB Hôpital Erasme, Brussels, Belgium.
ORCID profiles: Juma A Mohamedi, Claire Liefferinckx, Erwin Dreesen
Funding
- VLIRUOS
Cite
APA
Mohamedi, J. A., Liefferinckx, C., & Dreesen, E. (2026). Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71109
Vancouver
Mohamedi JA, Liefferinckx C, Dreesen E. Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71109
BibTeX
@article{Mohamedi2026,
author = {Mohamedi, Juma A and Liefferinckx, Claire and Dreesen, Erwin},
title = {Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing? Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71109}
}
EUVIMED